Tower Research Capital LLC (Trc) Angion Biomedica Corp. Transaction History

Tower Research Capital LLC (Trc)

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$0.48 - $1.02 $1,260 - $2,678	2,626 Added 73.37%	6,205 $4,000
Q4 2022 Feb 10, 2023	BUY	$0.8 - $1.0 $900 - $1,126	1,126 Added 45.9%	3,579 $3,000
Q3 2022 Nov 10, 2022	BUY	$0.94 - $1.23 $1,270 - $1,662	1,352 Added 122.8%	2,453 $2,000
Q2 2022 Aug 15, 2022	SELL	$1.1 - $2.23 $3,891 - $7,889	-3,538 Reduced 76.27%	1,101 $1,000
Q1 2022 May 12, 2022	BUY	$1.72 - $2.96 $746 - $1,284	434 Added 10.32%	4,639 $10,000
Q4 2021 Feb 14, 2022	BUY	$2.35 - $9.95 $7,216 - $30,556	3,071 Added 270.81%	4,205 $12,000
Q3 2021 Nov 15, 2021	BUY	$9.31 - $13.25 $400 - $569	43 Added 3.94%	1,134 $11,000
Q2 2021 Aug 16, 2021	BUY	$13.02 - $17.83 $4,674 - $6,400	359 Added 49.04%	1,091 $14,000
Q1 2021 May 17, 2021	BUY	$15.01 - $25.74 $10,987 - $18,841	732 New	732 $13,000

Ticker ANGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,113,300
Description
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.